Loading stock data...

Suraksha Diagnostic Limited

NSE: SURAKSHA BSE: SURAKSHA

NSE
314.25 -3.60 (-1.13%)

Prev Close

317.85

Open Price

314

Volume

11,678

Today Low / High

314 / 318.2

52 WK Low / High

231 / 449

Range

299 - 330

BSE
314.20 -2.05 (-0.65%)

Prev Close

316.25

Open Price

310.05

Volume

1,051

Today Low / High

310.05 / 316.3

52 WK Low / High

233.15 / 449

Range

298 - 330

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 314.25 (target range: 299 - 330), reflecting a change of -3.6 (-1.13261%). On the BSE, it is listed at 314.2 (target range: 298 - 330), showing a change of -2.05 (-0.64822%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

22 Aug 314.00 0.08%
21 Aug 316.05 0.06%
20 Aug 324.95 -3.19%
19 Aug 310.05 2.48%
18 Aug 302.30 3.90%
14 Aug 295.35 2.25%
13 Aug 298.00 0.91%
12 Aug 299.40 -0.20%
11 Aug 299.05 -0.69%
08 Aug 292.20 1.80%
07 Aug 288.00 2.76%
06 Aug 291.10 -0.31%
05 Aug 296.00 0.07%
04 Aug 241.20 22.74%
01 Aug 303.25 -0.59%
31 Jul 300.00 0.38%
30 Jul 301.10 1.66%
29 Jul 301.45 1.53%
28 Jul 303.05 0.56%

Suraksha Diagnostic Limited Graph

Suraksha Diagnostic Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Suraksha Diagnostic Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 314.25, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 314.20 317.34 285.61 - 349.08
320.48 256.39 - 384.58
323.63 226.54 - 420.71
Bearish Scenario 314.20 311.06 279.95 - 342.16
307.92 246.33 - 369.50
304.77 213.34 - 396.21

Overview of Suraksha Diagnostic Limited

ISIN

INE877V01027

Industry

Medical - Diagnostics & Research

Vol.Avg

55,005

Market Cap

16,366,377,887

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-06

DCF Diff

240.24

DCF

74

Financial Ratios Every Investor Needs

Stock Rating Details for SURAKSHA

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 252.09 Cr 29.52 Cr 222.57 Cr 0.8829 0.00 Cr 46.19 Cr 48.13 Cr 31.82 Cr 5.97 85.09 Cr 0.1262
2024-03-31 218.71 Cr 27.25 Cr 191.46 Cr 0.8754 0.00 Cr 34.53 Cr 40.83 Cr 23.63 Cr 4.54 73.66 Cr 0.1080
2023-03-31 190.13 Cr 27.40 Cr 162.73 Cr 0.8559 0.00 Cr 31.27 Cr 15.78 Cr 6.52 Cr 1.25 47.48 Cr 0.0343
2022-03-31 223.19 Cr 60.41 Cr 162.79 Cr 0.7294 0.00 Cr 24.53 Cr 36.65 Cr 20.82 Cr 4.00 65.25 Cr 0.0933
2021-03-31 140.01 Cr 32.90 Cr 107.10 Cr 0.7650 0.00 Cr 38.07 Cr 67.49 Cr 6.44 Cr 1.21 23.81 Cr 0.0460

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.25 Cr 333.52 Cr 123.29 Cr 211.2397 Cr 88.89 Cr 86.64 Cr 8.05 Cr 231.53 Cr 0.00 Cr 0.00 Cr 43.69 Cr 42.7166 Cr
2024-03-31 2.52 Cr 300.21 Cr 121.06 Cr 179.4080 Cr 90.48 Cr 87.96 Cr 6.68 Cr 216.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 39.4140 Cr
2023-03-31 2.16 Cr 281.20 Cr 125.73 Cr 155.9260 Cr 96.87 Cr 94.71 Cr 6.16 Cr 196.40 Cr 0.00 Cr 0.00 Cr -47.11 Cr 38.3410 Cr
2022-03-31 3.19 Cr 275.96 Cr 130.13 Cr 145.8420 Cr 99.80 Cr 96.61 Cr 6.23 Cr 198.52 Cr 0.00 Cr 0.00 Cr -33.38 Cr 38.3470 Cr
2021-03-31 2.93 Cr 171.05 Cr 44.82 Cr 126.2235 Cr 16.43 Cr 13.50 Cr 4.45 Cr 116.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 24.9561 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 63.3591 Cr -39.5841 Cr -24.0482 Cr 21.3351 Cr -0.2732 Cr 2.2468 Cr -42.0240 Cr 31.8241 Cr -2.8114 Cr 0.0000 Cr -1.3706 Cr
2024-03-31 60.4840 Cr -34.9960 Cr -25.1300 Cr 15.7900 Cr 0.3580 Cr 2.5200 Cr -44.6940 Cr 31.4530 Cr -5.3700 Cr 0.0000 Cr -0.5160 Cr
2023-03-31 44.0960 Cr -20.7950 Cr -24.3280 Cr 30.9290 Cr -1.0270 Cr 2.1620 Cr -13.1670 Cr 6.7480 Cr -5.0200 Cr 0.0000 Cr 0.0630 Cr
2022-03-31 57.8230 Cr -43.2810 Cr -14.2850 Cr 38.5740 Cr 0.2570 Cr 3.1890 Cr -19.2490 Cr 28.0120 Cr 2.5960 Cr 0.0000 Cr -1.7810 Cr
2021-03-31 23.5117 Cr -27.7083 Cr 3.2106 Cr 8.1111 Cr 2.9321 Cr 2.9321 Cr -15.4006 Cr 6.4351 Cr 4.8310 Cr 0.0000 Cr 1.0012 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 72.59 Cr 8.75 Cr 63.84 Cr 0.8794 13.38 Cr 9.40 Cr 1.80 24.66 Cr 0.1295
2025-03-31 65.09 Cr 27.78 Cr 37.31 Cr 0.5732 11.26 Cr 7.39 Cr 1.40 20.00 Cr 0.1135
2024-12-31 59.51 Cr 6.10 Cr 33.30 Cr 0.5595 9.43 Cr 6.15 Cr 1.18 18.86 Cr 0.1034
2024-09-30 66.75 Cr 7.93 Cr 39.05 Cr 0.5850 14.45 Cr 10.34 Cr 1.99 24.51 Cr 0.1549
2024-06-30 60.73 Cr 6.64 Cr 54.10 Cr 0.8907 12.23 Cr 7.94 Cr 1.52 21.72 Cr 0.1307

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 2.25 Cr 20.39 Cr 22.64 Cr 13.81 Cr 8.05 Cr 47.15 Cr 231.53 Cr 333.52 Cr 123.29 Cr
2024-12-31 0.00 Cr 0.00 Cr 56.68 Cr 0.00 Cr 0.00 Cr 56.68 Cr 0.00 Cr 0.00 Cr -196.80 Cr
2024-09-30 2.03 Cr 64.72 Cr 66.75 Cr 9.02 Cr 6.85 Cr 86.61 Cr 214.28 Cr 319.56 Cr 122.76 Cr
2024-06-30 4.42 Cr 53.19 Cr 57.61 Cr 11.62 Cr 6.32 Cr 81.55 Cr 222.01 Cr 314.20 Cr 127.58 Cr
2024-03-31 2.52 Cr 49.08 Cr 51.60 Cr 8.88 Cr 6.68 Cr 72.45 Cr 216.40 Cr 300.21 Cr 121.06 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 6.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr -2.03 Cr 0.00 Cr 2.03 Cr 0.00 Cr 0.00 Cr
2024-09-30 13.63 Cr 18.93 Cr -15.15 Cr -6.17 Cr -2.39 Cr 2.03 Cr 4.42 Cr -12.47 Cr 6.46 Cr
2024-06-30 10.51 Cr 18.35 Cr -10.07 Cr -6.39 Cr 1.90 Cr 4.42 Cr 2.52 Cr -7.44 Cr 10.91 Cr
2023-12-31 4.65 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 8.41 Cr 15.85 Cr -9.59 Cr -6.77 Cr 0.00 Cr 0.00 Cr 0.00 Cr -15.27 Cr 0.58 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Diagnostics & Research

Company Name Symbol Price Market Cap Volume
Dr. Lal PathLabs Limited LALPATHLAB ₹3,374.90 ₹281,976,398,146.00 ₹105,272.00
Metropolis Healthcare Limited METROPOLIS ₹2,169.50 ₹112,384,222,050.00 ₹21,497.00
Vijaya Diagnostic Centre Limited VIJAYA ₹1,021.10 ₹104,892,436,234.00 ₹338,876.00
Thyrocare Technologies Limited THYROCARE ₹1,271.70 ₹67,392,978,480.00 ₹102,297.00
Vimta Labs Limited VIMTALABS ₹657.75 ₹29,273,558,400.00 ₹1,724,053.00
Krsnaa Diagnostics Limited KRSNAA ₹809.15 ₹26,247,749,831.00 ₹22,390.00

Key Executives

Chief Sales Operations
Mr. Niren Kaul

Gender: male

Year Born:

Company Secretary & Compliance Officer
Ms. Mamta Jain

Gender: female

Year Born:

Chief Financial Officer
Mr. Ravindra K. S.

Gender: male

Year Born:

Joint MD, Chief Executive Officer & Director
Ms. Ritu Mittal

Gender: female

Year Born: 1973

FAQs about Suraksha Diagnostic Limited

Who is the CEO of the company?

The CEO is Ritu Mittal.

What is the current market price of the stock?

The current price is ₹314.25.

What is the 52-week price range?

The range is ₹231-449.

What is the market capitalization of the company?

The market capitalization is ₹1,636.64 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 49.29.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Suraksha Diagnostic Limited (ISIN: INE877V01027) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹1,636.64 crores and an average daily volume of 55,005 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack